Table 2.
Clearly defined purpose | Number of patients specified | Patient demographic information reported | Number of documents specified | Detailed description of NLP approach | Parameterization conducted | Inclusion of comparative evaluation | Detailed description of comparative evaluation design | Justification for evaluation design and metrics | Evaluation metrics reported | Statistical treatment of results (e.g., confidence tests) | Discussion of model costs (time, resources) and explainability | Availability of code and datasets for reproducibility | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coronary Artery Disease | |||||||||||||
Esteban et al, 20179 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
Hu et al, 201613 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Owlia et al, 201910 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
Safarova et al, 201611 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Shah et al, 201912 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Toerper et al, 201614 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||
Electrophysiology | |||||||||||||
Bean et al, 201916 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Hu et al, 201921 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
Moon et al, 201920 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
Moon et al, 202019 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Rosier et al, 201618 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Shah et al, 2020a17 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Shah et al, 2020b15 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
General cardiology | |||||||||||||
Viani et al, 201922 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Heart Failure | |||||||||||||
Alnazzawi et al, 201623 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
Bielinski et al, 201524 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
Eggerth et al, 202036 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Evans et al, 201630 | ✓ | ✓ | ✓ | ✓ | |||||||||
Garvin et al, 201833 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Jonnalagadda et al, 201734 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
Kaspar et al, 201825 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Leiter et al, 202037 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Liu et al, 201931 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Mahajan et al, 201932 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||
Patel et al, 201826 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||
Topaz et al, 201735 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Wagholikar et al, 201827 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Wang et al, 201528 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Zhang et al, 201829 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Imaging | |||||||||||||
Adekkanattu et al, 201938 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||
Nath et al, 201639 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Patterson et al, 201742 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Shi et al, 201540 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Valtchinov et al, 202043 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Xie et al, 201741 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Zheng et al, 202044 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Valvular Disease | |||||||||||||
Galper et al, 201845 | ✓ | ✓ | ✓ | ✓ | ✓ |